Symbol: |
KAZN
|
Description: |
kazrin, periplakin interacting protein [Source:HGNC Symbol;Acc:29173]
|
Location: |
Chr1:14925200-15444539[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:194
Gene |
Compound |
Gen_sig |
Exp_pattern |
KAZN |
NSC 382046 |
0.025 |
Up |
KAZN |
Veracoquinazole |
0.012 |
Up |
KAZN |
Camptothecin lysinate HCl |
0.033 |
Up |
KAZN |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.027 |
Down |
KAZN |
Benzoic acid, 2-hydroxy-, (2,6-pyridinediyldiethylidyne)dihydrazide, manganese chloride complex |
0.014 |
Down |
KAZN |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.025 |
Down |
KAZN |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.049 |
Down |
KAZN |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.001 |
Down |
KAZN |
Dichlorobis[1-(4-nitrophenyl)-3-phenylpropane-1,3-dionato]-titanium(IV) |
0.008 |
Up |
KAZN |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.03 |
Down |
KAZN |
(E)Methyl-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoate |
0.011 |
Up |
KAZN |
1,4-Naphthalenedione, 2-chloro-3-[[2-(2-fluorophenyl)- 1-oxoethyl]amino]- |
0.03 |
Down |
KAZN |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.025 |
Down |
KAZN |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.027 |
Down |
KAZN |
NSC 651668 |
0.021 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:94
Total:7 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|